Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venetoclax + HHT + AZA + G-CSF in Elderly AML
NCT04824924Phase 2Unknown
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Mar 2021
- Primary completion
- Mar 2024
- Modality
- Nucleic Acid-Directed Small Molecules, Covalent Small Molecules, Classical Binding Small Molecules
01
Overview
A Phase 2 trial of venetoclax, homoharringtonine in acute myeloid leukemia (AML), sponsored by Shanghai Jiao Tong University School of Medicine. Status: unknown.
02
Drugs
venetoclaxhomoharringtonine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT04824924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04824924.